Raimondo D. C.
- Country
- Italy
- Department
- UOSD Malattie Emorragiche e Trombotiche
Research Overview
- Evaluation of Emicizumab Prophylaxis on Joint Health and Physical Activity in Patients Aged ≥13 to <70 with Severe or Moderate Hemophilia A Without FVIII Inhibitors
- Evaluation of Long-Term Efficacy of Efanesoctocog Alfa Prophylaxis on Joint Health in Patients with Hemophilia A: A Low-Interventional Study
- A Phase 3, single-arm, multicenter, multinational, open-label, one-way crossover study to investigate the efficacy and safety of fitusiran prophylaxis in male participants aged ≥ 12 years with severe hemophilia A or B with or without inhibitory antibodies to factor VIII or IX
Data & Insights
Has run more than one trial at 8 of 47 partner sites.
Specializations
Hematological Disorders
The investigator specializes in the treatment and management of hemophilia, with particular emphasis on severe and moderate Hemophilia A. Their clinical research focuses on innovative therapeutic approaches for bleeding prevention and management.
- Bleeding disorder management
- Prophylactic treatment strategies
- Coagulation factor disorders
Their work encompasses evaluating novel subcutaneous treatments and prophylactic therapies for hemophilia patients.
Quality of Life Assessment
The investigator conducts comprehensive research on health-related quality of life outcomes in patients with bleeding disorders. Their studies evaluate the impact of various treatments on patients' overall wellbeing and daily activities.
- Physical activity assessment
- Joint health monitoring
- Patient-reported outcomes
Their research includes systematic evaluation of joint health and physical functionality in hemophilia patients.
Therapeutic Innovation
The investigator explores novel prophylactic treatments for hemophilia, including advanced therapies administered through subcutaneous injection. Their research aims to improve treatment effectiveness and patient compliance.
- Prophylaxis optimization
- Treatment efficacy assessment
- Bleeding episode prevention
Their work focuses on evaluating new therapeutic options for enhanced bleeding prevention in hemophilia patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.